(Q27852197)
Statements
1 reference
Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08). (English)
1 reference
July 2013
0 references
64
0 references
1
0 references
150-8
0 references
1 reference